134
Views
0
CrossRef citations to date
0
Altmetric
Fora

Glycaemic control: do no harm

, MD, MClinSci, CFPC (Professor)
Pages 6-7 | Received 31 Jan 2011, Accepted 23 Apr 2011, Published online: 15 Aug 2014

References

  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837–853.
  • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854–65.
  • Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009: 360: 1283–1297.
  • Patel A, MacMahon S, Chalmers J, Neal B, et al. Intensive blood glucose and vascular outcomes in patients with type 2 diabetes. NEJM. 2008; 358: 2560–2572.
  • Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358: 2545–2559.
  • Griesdale DE, De Souza RJ, Van Dam RM, et al. Intensive insulin therapy among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180: 821–827.
  • Montori VM, Fernandez-Balsells M. Glycemic control in type 2 diabetes: time for evidence-based about face? Ann Intern Med. 2009; 150(11): 803.
  • Nelson J, Dufraux K, Cook P. The relationship between glycemic control and falls in older adults. J Am Geriatr Soc. 2007; 55(12): 2041–2044.
  • Mallery L. State of the art: diabetes guidelines for the elderly residents in long-term care facilities. Newsletter of the Diabetes Care Program of Nova Scotia 2009; 19(1): 1 -2. Available from: http://www.diabetescareprogram.ns.ca/newsletter/2009/jan09.pdf
  • Alder AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000; 321: 412–419.
  • Perk J. Risk factor management: a practice guide. Eur J Cardiovasc Prev Rehabil. 2009; 3(2): S24–8.
  • Mann D, Woodward M, Muntner P. Preventing diabetes complications: are we too glucocentric? Int J Clin Pract. 2010; 64(8): 1024–1027.
  • Mann D, Woodward M, Ye F, et al. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. Arch Intern Med. 2009; 169(18): 1718–1720